EstechPharma Co. Ltd (041910) - Total Liabilities

Latest as of December 2025: ₩60.00 Billion KRW ≈ $40.66 Million USD

Based on the latest financial reports, EstechPharma Co. Ltd (041910) has total liabilities worth ₩60.00 Billion KRW (≈ $40.66 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore EstechPharma Co. Ltd net asset momentum to track the company's year-over-year net asset growth rate.

EstechPharma Co. Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how EstechPharma Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 041910 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

EstechPharma Co. Ltd Competitors by Total Liabilities

The table below lists competitors of EstechPharma Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Ekarat Engineering Public Company Limited BK:AKR	Thailand	฿486.51 Million
Planet Image International Limited Class A Ordinary Shares NASDAQ:YIBO	USA	$82.16 Million
Omesti Bhd KLSE:9008	Malaysia	RM74.50 Million
Zaklady Przemyslu Cukierniczego Otmuchow S.A. WAR:OTM	Poland	zł63.45 Million
Consus Enerji Isletmeciligi ve Hizmetleri AS IS:CONSE	Turkey	TL5.87 Billion
BrilliA Inc NYSE MKT:BRIA	USA	$15.92 Million
Korea Electronic Certification Authority Inc KQ:041460	Korea	₩20.07 Billion
Batavia Prosperindo Finance JK:BPFI	Indonesia	Rp1.16 Trillion

Liability Composition Analysis (2013–2025)

This chart breaks down EstechPharma Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of EstechPharma Co. Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EstechPharma Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EstechPharma Co. Ltd (2013–2025)

The table below shows the annual total liabilities of EstechPharma Co. Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩60.00 Billion ≈ $40.66 Million	+922.48%
2024-12-31	₩5.87 Billion ≈ $3.98 Million	-6.35%
2023-12-31	₩6.27 Billion ≈ $4.25 Million	-23.86%
2022-12-31	₩8.23 Billion ≈ $5.58 Million	-25.60%
2021-12-31	₩11.06 Billion ≈ $7.50 Million	-5.90%
2020-12-31	₩11.76 Billion ≈ $7.97 Million	-14.23%
2019-12-31	₩13.71 Billion ≈ $9.29 Million	+50.71%
2018-12-31	₩9.09 Billion ≈ $6.16 Million	-27.66%
2017-12-31	₩12.57 Billion ≈ $8.52 Million	-37.30%
2016-12-31	₩20.05 Billion ≈ $13.59 Million	+4.22%
2015-12-31	₩19.24 Billion ≈ $13.04 Million	-50.12%
2014-12-31	₩38.57 Billion ≈ $26.14 Million	+5.92%
2013-12-31	₩36.41 Billion ≈ $24.68 Million	--

About EstechPharma Co. Ltd

KQ:041910 Korea Pharmaceuticals

Market Cap

$40.76 Million

₩60.15 Billion KRW

Market Cap Rank

#22606 Global

#1419 in Korea

Share Price

₩5150.00

Change (1 day)

+10.52%

52-Week Range

₩4300.00 - ₩8920.00

All Time High

₩28269.41